The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ASSEMBLY BIOSCIENCES ORD | COM | 045396108 | 2,711 | 275,800 | SH | Call | SOLE | 275,800 | 0 | 0 | |
ASSEMBLY BIOSCIENCES ORD | COM | 045396108 | 2,187 | 222,500 | SH | Call | SOLE | 222,500 | 0 | 0 | |
FIBROGEN ORD | COM | 31572Q808 | 13,868 | 375,000 | SH | Call | SOLE | 375,000 | 0 | 0 | |
FIBROGEN ORD | COM | 31572Q808 | 10,262 | 277,500 | SH | Call | SOLE | 277,500 | 0 | 0 | |
GOSSAMER BIO INC ORD | COM | 38341P102 | 3,358 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
GOSSAMER BIO INC ORD | COM | 38341P102 | 10,074 | 600,000 | SH | Call | SOLE | 600,000 | 0 | 0 | |
ARCUS BIOSCIENCES ORD | COM | 03969F109 | 6,866 | 754,505 | SH | SOLE | 754,505 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES ORD | COM | 045396108 | 950 | 96,600 | SH | SOLE | 96,600 | 0 | 0 | ||
ATRECA CL A ORD | COM | 04965G109 | 18,132 | 1,481,411 | SH | SOLE | 1,481,411 | 0 | 0 | ||
CHIASMA ORD | COM | 16706W102 | 15,067 | 3,043,827 | SH | SOLE | 3,043,827 | 0 | 0 | ||
CORTEXYME ORD | COM | 22053A107 | 1,246 | 49,993 | SH | SOLE | 49,993 | 0 | 0 | ||
CURIS ORD | COM | 231269200 | 6,680 | 2,982,208 | SH | SOLE | 2,982,208 | 0 | 0 | ||
CYCLERION THERAPEUTICS ORD | COM | 23255M105 | 9,408 | 776,206 | SH | SOLE | 776,206 | 0 | 0 | ||
DICERNA PHARMACEUTICALS ORD | COM | 253031108 | 56,908 | 3,962,978 | SH | SOLE | 3,962,978 | 0 | 0 | ||
EIGER BIOPHARMACEUTICAL ORD | COM | 28249U105 | 10,865 | 1,060,043 | SH | SOLE | 1,060,043 | 0 | 0 | ||
EXICURE ORD | COM | 30205M101 | 13,954 | 5,515,225 | SH | SOLE | 5,515,225 | 0 | 0 | ||
FIBROGEN ORD | COM | 31572Q808 | 47,845 | 1,293,807 | SH | SOLE | 1,293,807 | 0 | 0 | ||
HARPOON THERAPEUTICS ORD | COM | 41358P106 | 19,990 | 1,463,423 | SH | SOLE | 1,463,423 | 0 | 0 | ||
IGM BIOSCIENCES ORD | COM | 449585108 | 1,775 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
IRONWOOD PHARMA CL A ORD | COM | 46333X108 | 40,104 | 4,671,408 | SH | SOLE | 4,671,408 | 0 | 0 | ||
KURA ONCOLOGY ORD | COM | 50127T109 | 61,316 | 4,041,953 | SH | SOLE | 4,041,953 | 0 | 0 | ||
MERUS ORD | COM | N5749R100 | 2,951 | 165,600 | SH | SOLE | 165,600 | 0 | 0 | ||
MIRATI THERAPEUTICS ORD | COM | 60468T105 | 3,445 | 44,221 | SH | SOLE | 44,221 | 0 | 0 | ||
MORPHIC HOLDING ORD | COM | 61775R105 | 39,145 | 2,161,520 | SH | SOLE | 2,161,520 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS ORD | COM | 64049K104 | 6,458 | 2,265,880 | SH | SOLE | 2,265,880 | 0 | 0 | ||
NEXTCURE ORD | COM | 65343E108 | 7,728 | 250,500 | SH | SOLE | 250,500 | 0 | 0 | ||
PREVAIL THERAPEUTICS ORD | COM | 74140Y101 | 29,381 | 2,392,556 | SH | SOLE | 2,392,556 | 0 | 0 | ||
PROTHENA ORD | COM | G72800108 | 73,905 | 9,426,640 | SH | SOLE | 9,426,640 | 0 | 0 | ||
REGULUS THERAPEUTICS ORD | COM | 75915K200 | 755 | 1,049,088 | SH | SOLE | 1,049,088 | 0 | 0 | ||
RUBIUS THERAPEUTICS ORD | COM | 78116T103 | 2,042 | 260,152 | SH | SOLE | 260,152 | 0 | 0 | ||
SAREPTA THERAPEUTICS ORD | COM | 803607100 | 14,292 | 189,745 | SH | SOLE | 189,745 | 0 | 0 | ||
SOLID BIOSCIENCES ORD | COM | 83422E105 | 34,563 | 3,342,691 | SH | SOLE | 3,342,691 | 0 | 0 | ||
SPARK THERAPEUTICS ORD | COM | 84652J103 | 69,320 | 714,789 | SH | SOLE | 714,789 | 0 | 0 | ||
SURFACE ONCOLOGY ORD | COM | 86877M209 | 2,199 | 1,548,888 | SH | SOLE | 1,548,888 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL ORD | COM | 90400D108 | 2,633 | 61,554 | SH | SOLE | 61,554 | 0 | 0 | ||
UNITY BIOTECHNOLOGY ORD | COM | 91381U101 | 314 | 51,400 | SH | SOLE | 51,400 | 0 | 0 | ||
VERICEL ORD | COM | 92346J108 | 1,983 | 131,001 | SH | SOLE | 131,001 | 0 | 0 | ||
XENCOR ORD | COM | 98401F105 | 84,378 | 2,501,557 | SH | SOLE | 2,501,557 | 0 | 0 | ||
ZAFGEN ORD | COM | 98885E103 | 1,437 | 1,944,500 | SH | SOLE | 1,944,500 | 0 | 0 | ||
ARGENX ADR REP ORD | SPONSORED ADR | 04016X101 | 60,532 | 531,165 | SH | SOLE | 531,165 | 0 | 0 | ||
AUTOLUS THERAPEUTICS ADR | SPONSORED ADR | 05280R100 | 859 | 69,155 | SH | SOLE | 69,155 | 0 | 0 |